Overhaul of MSK research needed: experts

Funding for musculoskeletal (MSK) clinical trials in Australia is disproportionately low and many trials are not addressing the most critical issues, according to a new analysis.

While MSK conditions are the leading contributor to Australia’s disability burden, they attract only 0.8% of grants and funding from the National Health and Medical Research Council, the report published this week in the MJA found.

Over the past two years only one in 20

Latest

Trending